Month: May 2025

KULR Technology Group Set to Join Russell 3000® Index

Written by Customer Service on May 27, 2025. Posted in Public Companies.

HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in sustainable energy management, today announced it is set to join the broad-market Russell 3000® Index, effective after the United States market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective,...

ZenaTech Provides Quantum Computing Update on ‘Clear Sky’ Weather Forecasting Project─AI Drone Swarms to Combat Steep Rise in Billion Dollar Extreme Weather Events

Written by Customer Service on May 27, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today provides an update on its “Clear Sky” project, an R&D initiative soon to be released in a beta application version, that uses multiple AI drones in a drone swarm, and quantum computing for weather forecasting. The goal is to better predict localized weather including extreme weather events for business and government users, saving lives and billions of dollars. In the coming months, ZenaTech plans to expand its quantum computing project team to 20 by adding at least ten additional specialized engineers. This will accelerate the development...

IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025

Written by Customer Service on May 27, 2025. Posted in Public Companies.

Presentation at ESMO will follow oral 2025 ASCO Annual Meeting presentation highlighting unprecedented survival data from Phase 2 OVATION 2 Study of IMNN-001 Simultaneously publication in leading peer-reviewed journal Gynecologic Oncology details IMNN-001’s outstanding safety and efficacy across multiple analyses and subgroups Treatment with IMNN-001 could represent new promise for estimated 40,000 women newly diagnosed with advanced ovarian cancer yearly in EU and 300,000 globally LAWRENCEVILLE, N.J., May 27, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting IMNN-001 data based on an immune biomarker analysis from the Phase 2 OVATION 2 Study in women with newly diagnosed advanced ovarian cancer was...

Inseego Selected for Preliminary Inclusion in the Russell 2000® Index

Written by Customer Service on May 27, 2025. Posted in Public Companies.

Company Visibility Further Strengthened as Company Continues to Advance Strategic and Financial Transformation Under New CEO Juho Sarvikas SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) — Inseego Corp. (Nasdaq: INSG) (“Inseego” or the “Company”), a global leader in wireless broadband, including 5G mobile broadband and 5G fixed wireless access (FWA) solutions, today announced it has been selected for preliminary inclusion in the Russell 2000® Index, based on the May 23, 2025, preliminary additions list published by FTSE Russell. Final membership and index assignments will be confirmed following the annual reconstitution, which takes effect after the market closes on June 28, 2025. The Russell 2000® Index is a widely followed benchmark for small-cap U.S. equities and includes the smallest 2,000 companies in the broader Russell 3000® Index....

Bridger Aerospace Announces Signing of Sale Leaseback Transaction for its Headquarters Campus; Strengthening Balance Sheet and Reducing Annual Interest Expense

Written by Customer Service on May 27, 2025. Posted in Public Companies.

BELGRADE, Mont., May 27, 2025 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger,” “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported that it has signed a Purchase and Sale Agreement for a sale leaseback transaction for its Bozeman Yellowstone International Airport campus facilities in Belgrade, Montana, with an aggregate purchase price of at least $46 million. The net proceeds from the transaction will be used to repay a portion of the outstanding balance under the Company’s debt facilities, lowering ongoing cash interest. The transaction is expected to close in the third quarter of 2025 and is subject to customary closing conditions. Concurrent with the closing of the transaction, Bridger will enter into a ten-year lease agreement...

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

Written by Customer Service on May 27, 2025. Posted in Public Companies.

NEEDHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Candel management will host a webcast and conference call on Tuesday, June 3, 2025, at 1:00PM ET. The call will discuss the Company’s positive phase 3 clinical results for CAN-2409 in localized, intermediate-to-high risk prostate cancer, which demonstrated a statistically significant 30% reduction in disease recurrence compared with placebo when combined with standard-of-care radiation therapy. The discussion will follow Dr. Theodore DeWeese’s* oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The call will also feature insights...

StepStone Group to Present at the Morgan Stanley US Financials Conference

Written by Customer Service on May 27, 2025. Posted in Public Companies.

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Morgan Stanley US Financials Conference on Tuesday, June 10, 2025, at 2:30 pm ET. A live webcast and replay will be accessible through the StepStone website at https://shareholders.stepstonegroup.com. About StepStone StepStone Group Inc. (Nasdaq: STEP) is a global private markets investment firm focused on providing customized investment solutions and advisory and data services to its clients. As of March 31, 2025, StepStone was responsible for approximately $709 billion of total capital, including $189 billion of assets under management. StepStone’s clients include some of the world’s largest public and private defined benefit and defined...

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June

Written by Customer Service on May 27, 2025. Posted in Public Companies.

NAARDEN, the Netherlands and MIAMI, May 27, 2025 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the following upcoming investor conferences:William Blair 45th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 3, 2025. Michael Davidson, M.D., Chief Executive Officer, will present a corporate overview at 3:20 p.m. CT on Tuesday, June 3. Jefferies Global Healthcare Conference 2025 in New York, NY on Wednesday, June 4, 2025. Ian...

Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma

Written by Customer Service on May 27, 2025. Posted in Public Companies.

Novel combination with efti has met the trial’s primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcoma Detailed results are planned for presentation at a future medical meeting SYDNEY, AUSTRALIA, May 27, 2025 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces the investigator-initiated EFTISARC-NEO Phase II trial evaluating eftilagimod alfa (efti) with radiotherapy plus KEYTRUDA® (pembrolizumab) in the neoadjuvant setting for resectable soft tissue sarcoma (STS) has met its primary endpoint. The novel combination significantly exceeded the study’s prespecified median of 35% tumour hyalinization/fibrosis versus 15% for historical...

Check Point to Acquire Veriti to Transform Threat Exposure Management and Reduce Organizations’ Cyber Attack Surface

Written by Customer Service on May 27, 2025. Posted in Mergers And Acquisitions.

Veriti is the first to introduce preemptive exposure management delivering automated remediation of threat exposure risks and collaborative threat prevention across complex multi-vendor environments REDWOOD CITY, Calif., May 27, 2025 (GLOBE NEWSWIRE) — AI-fueled attacks and hyperconnected IT environments have made threat exposure one of the most urgent cybersecurity challenges facing enterprises today. In response, Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, today announced a definitive agreement to acquire Veriti Cybersecurity, the first fully automated, multi-vendor pre-emptive threat exposure and mitigation platform. “The acquisition of Veriti marks a significant step toward realizing our hybrid mesh security vision,” said Nadav Zafrir, CEO at Check Point Software...

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals